MICHELLE PURTLE: Open Payments
NPI 1659364222 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,256 in 76 payments from 15 companies in 2025. Trend: 2023 $1,115 · 2024 $1,191 · 2025 $3,256
Food & beverage: $1,837Consulting: $1,320Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4 | $1,449 |
| Janssen Biotech, Inc. | 11 | $362 |
| Galderma Laboratories, L.P. | 7 | $236 |
| ABBVIE INC. | 11 | $213 |
| PFIZER INC. | 6 | $209 |
| GENZYME CORPORATION | 5 | $150 |
| Arcutis Biotherapeutics, Inc. | 7 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $112 |
| Organon LLC | 1 | $75 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Zoryve, LITFULO, SKYRIZI, ILUMYA, RINVOQ.
Industry payments across TX — which companies pay providers there.
